Research suggests that a lower dose of immunotherapy may increase its effectiveness in treating melanoma patients. The approach to immunotherapy is being explored from various angles, including its potential interaction with dietary factors, anti-inflammatory drugs, and other substances. Studies are investigating different strategies to enhance immunotherapy efficacy, although the specific mechanisms and outcomes are still being studied.